TY - JOUR
T1 - Mitochondrial dysfunction in fibroblasts of Multiple System Atrophy
AU - Monzio Compagnoni, Giacomo
AU - Kleiner, Giulio
AU - Bordoni, Andreina
AU - Fortunato, Francesco
AU - Ronchi, Dario
AU - Salani, Sabrina
AU - Guida, Marianna
AU - Corti, Corrado
AU - Pichler, Irene
AU - Bergamini, Christian
AU - Fato, Romana
AU - Pellecchia, Maria Teresa
AU - Vallelunga, Annamaria
AU - Del Sorbo, Francesca
AU - Elia, Antonio
AU - Elia, Antonio Emanuele
AU - Reale, Chiara
AU - Garavaglia, Barbara
AU - Mora, Gabriele
AU - Albanese, Alberto
AU - Cogiamanian, Filippo
AU - Ardolino, Gianluca
AU - Bresolin, Nereo
AU - Corti, Stefania
AU - Comi, Giacomo P.
AU - Quinzii, Catarina M.
AU - Di Fonzo, Alessio
PY - 2018
Y1 - 2018
N2 - Multiple System Atrophy is a severe neurodegenerative disorder which is characterized by a variable clinical presentation and a broad neuropathological spectrum. The pathogenic mechanisms are almost completely unknown. In the present study, we established a cellular model of MSA by using fibroblasts’ primary cultures and performed several experiments to investigate the causative mechanisms of the disease, with a particular focus on mitochondrial functioning. Fibroblasts’ analyses (7 MSA-P, 7 MSA-C and 6 healthy controls) displayed several anomalies in patients: an impairment of respiratory chain activity, in particular for succinate Coenzyme Q reductase (p < 0.05), and a reduction of complex II steady-state level (p < 0.01); a reduction of Coenzyme Q10 level (p < 0.001) and an up-regulation of some CoQ10 biosynthesis enzymes, namely COQ5 and COQ7; an impairment of mitophagy, demonstrated by a decreased reduction of mitochondrial markers after mitochondrial inner membrane depolarization (p < 0.05); a reduced basal autophagic activity, shown by a decreased level of LC3 II (p < 0.05); an increased mitochondrial mass in MSA-C, demonstrated by higher TOMM20 levels (p < 0.05) and suggested by a wide analysis of mitochondrial DNA content in blood of large cohorts of patients. The present study contributes to understand the causative mechanisms of Multiple System Atrophy. In particular, the observed impairment of respiratory chain activity, mitophagy and Coenzyme Q10 biosynthesis suggests that mitochondrial dysfunction plays a crucial role in the pathogenesis of the disease. Furthermore, these findings will hopefully contribute to identify novel therapeutic targets for this still incurable disorder.
AB - Multiple System Atrophy is a severe neurodegenerative disorder which is characterized by a variable clinical presentation and a broad neuropathological spectrum. The pathogenic mechanisms are almost completely unknown. In the present study, we established a cellular model of MSA by using fibroblasts’ primary cultures and performed several experiments to investigate the causative mechanisms of the disease, with a particular focus on mitochondrial functioning. Fibroblasts’ analyses (7 MSA-P, 7 MSA-C and 6 healthy controls) displayed several anomalies in patients: an impairment of respiratory chain activity, in particular for succinate Coenzyme Q reductase (p < 0.05), and a reduction of complex II steady-state level (p < 0.01); a reduction of Coenzyme Q10 level (p < 0.001) and an up-regulation of some CoQ10 biosynthesis enzymes, namely COQ5 and COQ7; an impairment of mitophagy, demonstrated by a decreased reduction of mitochondrial markers after mitochondrial inner membrane depolarization (p < 0.05); a reduced basal autophagic activity, shown by a decreased level of LC3 II (p < 0.05); an increased mitochondrial mass in MSA-C, demonstrated by higher TOMM20 levels (p < 0.05) and suggested by a wide analysis of mitochondrial DNA content in blood of large cohorts of patients. The present study contributes to understand the causative mechanisms of Multiple System Atrophy. In particular, the observed impairment of respiratory chain activity, mitophagy and Coenzyme Q10 biosynthesis suggests that mitochondrial dysfunction plays a crucial role in the pathogenesis of the disease. Furthermore, these findings will hopefully contribute to identify novel therapeutic targets for this still incurable disorder.
KW - Autophagy
KW - Cells, Cultured
KW - Cellular models
KW - DNA, Mitochondrial
KW - Electron Transport Complex II
KW - Female
KW - Fibroblasts
KW - Humans
KW - Male
KW - Membrane Potential, Mitochondrial
KW - Mitochondria
KW - Mitophagy
KW - Multiple System Atrophy
KW - Ubiquinone
KW - Autophagy
KW - Cells, Cultured
KW - Cellular models
KW - DNA, Mitochondrial
KW - Electron Transport Complex II
KW - Female
KW - Fibroblasts
KW - Humans
KW - Male
KW - Membrane Potential, Mitochondrial
KW - Mitochondria
KW - Mitophagy
KW - Multiple System Atrophy
KW - Ubiquinone
UR - http://hdl.handle.net/10807/154897
U2 - 10.1016/j.bbadis.2018.09.018
DO - 10.1016/j.bbadis.2018.09.018
M3 - Article
SN - 0925-4439
VL - 1864
SP - 3588
EP - 3597
JO - BIOCHIMICA ET BIOPHYSICA ACTA. MOLECULAR BASIS OF DISEASE
JF - BIOCHIMICA ET BIOPHYSICA ACTA. MOLECULAR BASIS OF DISEASE
ER -